What Artelon does

Artelon is a medical device company that develops and commercializes proprietary biomaterial implants for tendon and ligament reconstruction, with primary focus on ankle instability. The company markets a portfolio of single-use sterile procedure kits — FLEXBAND TWIST, Solo, Multi, and FIX systems, FLEXBAND Plus, and FLEXPATCH — all built on its patented Dynamic Matrix technology, a co-polymer of polycaprolactone and polyurethane-urea knitted into a textile with cell-specific porosity (50% of pores 21-100µm for fibroblasts, 20% of pores 100-400µm for osteoblasts). The material is designed to provide strength and elasticity that mimic native soft tissue, integrate into regenerating tissue, and fully degrade over 4-6 years. Artelon reports over 60,000 implantations worldwide and 20+ years of clinical experience, with FDA 510(k) clearances (K230316 and K200503) covering reinforcement of soft tissue during tendon and ligament repair surgery across multiple joints.

The company was founded by orthopedic surgeon Lars Peterson, MD/PhD, based on his clinical experience with failed synthetic ligament devices. Artelon sells its implants through a direct sales force of agents working with orthopedic surgeons, supported by peer-driven cadaveric educational workshops, a tiered surgeon certification program (PRO, MASTER, Expert), and a public surgeon locator tool. Customers are surgeons performing soft tissue reconstruction in the foot/ankle, knee, and upper extremity. Revenue is generated through one-time hardware sales of sterile blister-packaged procedure kits; pricing is quote-based and not publicly disclosed. The company was venture-backed — Vensana Capital led a $20 million Series B in May 2023 — and was acquired by Stryker Corporation in 2023, with current headquarters at 8601 Dunwoody Place, Suite 250, Sandy Springs, GA. Prior to the acquisition, CEO Aaron Smith led the company, and Aaron Smith signed the SEC Form D filing in June 2023.

Name

Artelon

Legal name

Artelon, Inc.

Website

https://artelon.com

Company type

Private

Founded year

2013

Operating status

Acquired

Headcount range

11–50 employees

Short description

Artelon is a medical device company that develops and sells proprietary biomaterial implants for tendon and ligament reconstruction, with a focus on ankle instability. Its FLEXBAND product line, built on patented Dynamic Matrix co-polymer technology, is sold directly to orthopedic surgeons as single-use sterile procedure kits.

Ownership category

akta.pro rank

Product category

Orthopedic Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

akta.pro secondary industry

Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB)

Keywords

• Orthopedic soft tissue reconstruction
• Tendon ligament reinforcement
• Bio-textile medical implants
• Ankle instability solutions
• Dynamic matrix biomaterial

Headquarters

HQ city

Marietta

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

1. Medical Device Implants: Artelon generates revenue through the sale of medical implants including FLEXBAND, FLEXBAND Plus, and FLEXPATCH products sold to surgeons and healthcare providers for soft tissue reconstruction procedures. Products are sold as single-use, sterile blister packages with procedure kits.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Artelon designs, manufactures, and sells bio-textile surgical implants used by orthopedic surgeons for the reinforcement of tendon and ligament repairs, particularly for ankle instability. Its flagship product line, FLEXBAND, is built on a patented Dynamic Matrix co-polymer textile combining polycaprolactone and polyurethane-urea, delivered as single-use sterile procedure kits (TWIST, Solo, Multi, FIX), with FLEXBAND Plus and FLEXPATCH variants. The company sells directly to surgeons and healthcare institutions through a dedicated sales agent network.

Product overview

Artelon offers a unified portfolio of surgical implant products built around its proprietary Dynamic Matrix technology. The core product line includes the FLEXBAND family of systems (TWIST, Solo, Multi, and FIX), each providing complete sets of tools and implants in single-use sterile configurations targeting specific surgical indications. These systems are complemented by FLEXBAND Plus (premium matrix with integrated stitching) and FLEXPATCH (thinner matrix for broad augmentation). All products utilize a patented co-polymer of polycaprolactone and polyurethane-urea, knitted into a dynamic matrix designed to provide enhanced strength and elasticity while integrating with regenerating tissue over 4-6 years.

Differentiator

Problem solved

Functional benefit

Brands

• FLEXBAND: Next-generation biomaterial implant designed to restore natural strength and elasticity to healing soft tissues for tendon and ligament reconstruction. Includes FLEXBAND Twist, FLEXBAND Solo, FLEXBAND Multi, and FLEXBAND FIX systems.
• FLEXBAND Plus
• FLEXPATCH
• Dynamic Matrix

Products and services

• FLEXBAND TWIST System Flagship FLEXBAND system featuring twist-in anchor locking and a MOD cube for interoperative adaptability, offered as a complete single-use sterile kit targeting specific indications in soft tissue reconstruction.
• FLEXBAND Solo System Comprehensive procedure kit with tap-in fixation designed for single ligament augmentation procedures.
• FLEXBAND Multi System Comprehensive procedure kit with tap-in fixation designed for multiple ligament augmentation procedures.
• FLEXBAND FIX System Scaled-down procedure kit with tap-in fixation intended for single ligament augmentation.
• FLEXBAND Plus Premium FLEXBAND Matrix product line available in three different widths and multiple lengths, featuring integrated size 0 braided polyblend non-absorbable whip-stitching for quick matrix passing and fixation.
• FLEXBAND Matrix 1.2mm thick Dynamic Matrix commonly utilized in the repair and reconstruction of soft tissues throughout the extremities, designed with cell-specific porosity for rapid integration into regenerating tissue.
• FLEXPATCH Dynamic matrix product approximately 0.7mm thick (half the thickness of FLEXBAND), favored when broad dynamic augmentation is needed.

Quantifiable outcome

• Studies show suture repair alone may restore less than 50% of tissue's original strength, while FLEXBAND provides additional construct strength similar to native ankle ligaments
• +2 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• StrykercoreStrategic or Co-development PartnerArtelon is now part of Stryker following an acquisition. The company website displays 'Now part of Stryker' branding and references Stryker's privacy policy, terms of use, and ethics hotline.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Arthrex: A leading private orthopedic medical device company specializing in sports medicine and soft tissue repair. Arthrex's InternalBrace ligament augmentation system is the most direct competitor to Artelon's FLEXBAND, addressing the same ankle instability and ligament reconstruction market with similar surgical techniques.
• Integra LifeSciences: Specialized medical device company with strength in regenerative tissue technologies and orthopedic extremity solutions. Integra produces regenerative collagen matrices and tendon/ligament repair products that directly overlap with Artelon's bio-textile Dynamic Matrix offering in soft tissue reconstruction.
• Conmed: Medical device company with a dedicated Sports Medicine franchise offering arthroscopic instruments, suture anchors, and soft tissue fixation devices for ligament and tendon repair. Comparable to Artelon in serving foot/ankle and knee soft tissue reconstruction procedures.
• Paragon 28: Specialized foot and ankle orthopedic medical device company focused exclusively on extremity procedures. Paragon 28's dedicated foot/ankle surgeon network and surgical implant portfolio make it a direct peer to Artelon in ankle instability soft tissue reconstruction.

Broad incumbents

• Smith+Nephew: Global medical device company with a significant Sports Medicine franchise offering ACL/PCL reconstruction, shoulder repair, and biologic solutions for soft tissue injuries. Comparable to Artelon as a competing supplier to orthopedic surgeons performing ligament and tendon reconstruction procedures.
• DePuy Synthes (Johnson & Johnson MedTech): Johnson & Johnson's orthopedic medical device arm with a comprehensive sports medicine and trauma portfolio. DePuy Synthes serves the same orthopedic surgeon customer base as Artelon, with overlapping soft tissue repair and ligament reconstruction product lines.
• DJO (Enovis): Medical device company (formerly DJO Global) with a strong foot and ankle, sports medicine, and bracing portfolio. Enovis/DJO addresses adjacent orthopedic soft tissue and reconstruction markets served by Artelon, including ligament augmentation and orthopedic extremities.
• Stryker: Artelon's parent company and one of the world's largest medical device companies. Stryker's Sports Medicine and Foot & Ankle divisions include arthroscopy, suture anchors, and soft tissue fixation products that overlap with and may compete against Artelon's FLEXBAND platform within Stryker's own portfolio.
• Zimmer Biomet: Large orthopedic medical device company with sports medicine, extremities, and trauma offerings. Zimmer Biomet competes in soft tissue fixation and ligament reconstruction, addressing many of the same ankle instability and tendon repair indications as Artelon's FLEXBAND.

Emerging players

• MiMedx: Regenerative medicine company producing placental tissue allografts and soft tissue repair products. MiMedx addresses soft tissue reconstruction with a biologic (rather than synthetic textile) approach, representing an alternative technology path competing for the same tendon and ligament repair procedures that Artelon's FLEXBAND targets.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/artelon
• Instagraminstagram.com/flexband_by_artelon
• Xx.com/ArtelonM
• Facebookfacebook.com/ArtelonFLEXBAND

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Artelon